• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SHOX2 表达升高与肝细胞癌肿瘤复发相关。

Elevated SHOX2 expression is associated with tumor recurrence of hepatocellular carcinoma.

机构信息

Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China.

出版信息

Ann Surg Oncol. 2013 Dec;20 Suppl 3:S644-9. doi: 10.1245/s10434-013-3132-1. Epub 2013 Jul 13.

DOI:10.1245/s10434-013-3132-1
PMID:23851611
Abstract

BACKGROUND

SHOX2 (short stature homeobox 2) is a crucial transcriptional regulator in several genetic disorders and has been demonstrated to be an excellent biomarker in the diagnosis and evaluation of lung cancer. However, its expression pattern and prognostic value for hepatocellular carcinoma (HCC) are still unknown.

METHODS

Expression of SHOX2 gene and protein in HCC tissues and cell lines were evaluated by RT-qPCR and western blot. Impact of RNAi-mediated SHOX2 silence on the proliferation and invasion ability of Huh7 cell line in vitro was determined by CCK-8 assay and matrigel invasion assay, respectively.

RESULTS

Elevated expression of SHOX2 gene was significantly associated with higher incidence of tumor recurrence (n = 60, p = 0.001), absence of tumor capsule (p = 0.015), presence of tumor thrombi (p < 0.0001), and advanced TNM stage (p < 0.0001) of HCC. SHOX2 protein expression was more abundant in HCC cell lines compared with hepatic cell line (p = 0.001), which was associated with tumor recurrence (n = 40, p = 0.046). RNAi-mediated silence of SHOX2 expression significantly inhibited the proliferation (p < 0.001) and invasion (p = 0.006) of Huh7 cell line in vitro.

CONCLUSIONS

Elevated SHOX2 expression was associated with HCC recurrence, probably by enhancing proliferation and invasion capability of cancer cells.

摘要

背景

SHOX2(短肢同源盒 2)是几种遗传疾病中的关键转录调节因子,已被证明是诊断和评估肺癌的优秀生物标志物。然而,其在肝细胞癌(HCC)中的表达模式和预后价值尚不清楚。

方法

通过 RT-qPCR 和 Western blot 评估 SHOX2 基因和蛋白在 HCC 组织和细胞系中的表达。通过 CCK-8 测定和基质胶侵袭测定分别确定 RNAi 介导的 SHOX2 沉默对 Huh7 细胞系体外增殖和侵袭能力的影响。

结果

SHOX2 基因的高表达与肿瘤复发(n=60,p=0.001)、无肿瘤包膜(p=0.015)、存在肿瘤血栓(p<0.0001)和晚期 TNM 分期(p<0.0001)的 HCC 发生率显著相关。与肝细胞系相比,SHOX2 蛋白在 HCC 细胞系中的表达更为丰富(p=0.001),与肿瘤复发(n=40,p=0.046)相关。SHOX2 表达的 RNAi 介导沉默显著抑制 Huh7 细胞系的体外增殖(p<0.001)和侵袭(p=0.006)。

结论

SHOX2 表达升高与 HCC 复发相关,可能通过增强癌细胞的增殖和侵袭能力。

相似文献

1
Elevated SHOX2 expression is associated with tumor recurrence of hepatocellular carcinoma.SHOX2 表达升高与肝细胞癌肿瘤复发相关。
Ann Surg Oncol. 2013 Dec;20 Suppl 3:S644-9. doi: 10.1245/s10434-013-3132-1. Epub 2013 Jul 13.
2
Loss of FOXF2 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients.FOXF2表达缺失预示肝细胞癌患者预后不良。
Ann Surg Oncol. 2016 Jan;23(1):211-7. doi: 10.1245/s10434-015-4515-2. Epub 2015 Mar 31.
3
Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma.膜联蛋白A4的过表达提示预后不良,并促进肝细胞癌的肿瘤转移。
Tumour Biol. 2016 Jul;37(7):9343-55. doi: 10.1007/s13277-016-4823-6. Epub 2016 Jan 16.
4
Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma.Ack1过表达促进肝细胞癌转移并提示预后不良。
Oncotarget. 2015 Dec 1;6(38):40622-41. doi: 10.18632/oncotarget.5872.
5
A survey of c-MET expression and amplification in 287 patients with hepatocellular carcinoma.287 例肝细胞癌患者中 c-MET 表达和扩增的调查。
Anticancer Res. 2013 Nov;33(11):5179-86.
6
TREM-1, an inflammatory modulator, is expressed in hepatocellular carcinoma cells and significantly promotes tumor progression.触发受体表达分子-1(TREM-1)作为一种炎症调节因子,在肝癌细胞中表达,并显著促进肿瘤进展。
Ann Surg Oncol. 2015 Sep;22(9):3121-9. doi: 10.1245/s10434-014-4191-7. Epub 2014 Dec 3.
7
The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.β2-肾上腺素能受体是人肝癌根治性切除术后的一个潜在预后生物标志物。
Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.
8
Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.DAB2IP 低表达促进肝癌的恶性发展和不良预后。
J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.
9
Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma.SAMSN1表达的抑制与肝细胞癌的恶性表型相关。
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1453-60. doi: 10.1245/s10434-015-4524-1. Epub 2015 Mar 25.
10
Upregulation of miR-650 is correlated with down-regulation of ING4 and progression of hepatocellular carcinoma.miR-650 的上调与 ING4 的下调相关,并与肝癌的进展相关。
J Surg Oncol. 2013 Feb;107(2):105-10. doi: 10.1002/jso.23210. Epub 2012 Jul 5.

引用本文的文献

1
Mechanisms underlying hepatocellular carcinoma progression through N6-methyladenosine modifications of long non-coding RNA.长链非编码RNA的N6-甲基腺苷修饰促进肝细胞癌进展的潜在机制
World J Gastroenterol. 2025 Jun 7;31(21):103184. doi: 10.3748/wjg.v31.i21.103184.
2
N6-methyladenosine-modified long non-coding RNA promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression.N6-甲基腺苷修饰的长链非编码RNA通过上调SHOX2表达促进肝细胞癌的干性和索拉非尼耐药性。
World J Gastroenterol. 2024 Dec 28;30(48):5174-5190. doi: 10.3748/wjg.v30.i48.5174.
3
SHOX2 promotes prostate cancer proliferation and metastasis through disruption of the Hippo-YAP pathway.
SHOX2通过破坏Hippo-YAP信号通路促进前列腺癌的增殖和转移。
iScience. 2023 Aug 11;26(9):107617. doi: 10.1016/j.isci.2023.107617. eCollection 2023 Sep 15.
4
A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2.作为一种潜在的免疫治疗和预后生物标志物,SHOX2 可用于多种肿瘤,包括神经胶质瘤。
Hereditas. 2023 May 11;160(1):21. doi: 10.1186/s41065-023-00279-8.
5
System analysis based on the migration- and invasion-related gene sets identifies the infiltration-related genes of glioma.基于迁移和侵袭相关基因集的系统分析可识别胶质瘤的浸润相关基因。
Front Oncol. 2023 Apr 6;13:1075716. doi: 10.3389/fonc.2023.1075716. eCollection 2023.
6
MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2.miR-24-1-5p 通过靶向 SHOX2 抑制肾透明细胞癌的恶性表型。
Biochem Genet. 2023 Oct;61(5):2004-2019. doi: 10.1007/s10528-023-10353-5. Epub 2023 Mar 14.
7
The m6A/m5C/m1A Regulated Gene Signature Predicts the Prognosis and Correlates With the Immune Status of Hepatocellular Carcinoma.m6A/m5C/m1A 调控基因特征可预测肝细胞癌的预后,并与免疫状态相关。
Front Immunol. 2022 Jun 27;13:918140. doi: 10.3389/fimmu.2022.918140. eCollection 2022.
8
Integrated Transcriptome Profiling Identifies Prognostic Hub Genes as Therapeutic Targets of Glioblastoma: Evidenced by Bioinformatics Analysis.整合转录组分析确定预后关键基因作为胶质母细胞瘤的治疗靶点:基于生物信息学分析的证据
ACS Omega. 2022 Jun 22;7(26):22531-22550. doi: 10.1021/acsomega.2c01820. eCollection 2022 Jul 5.
9
Detection of SHOX2 DNA methylation by methylation-specific PCR in non-small cell lung cancer.采用甲基化特异性PCR检测非小细胞肺癌中SHOX2基因的DNA甲基化
Transl Cancer Res. 2020 Oct;9(10):6070-6077. doi: 10.21037/tcr-20-887.
10
SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3.SHOX2 通过转录激活 WASF3 与 STAT3 合作促进乳腺癌转移。
J Exp Clin Cancer Res. 2021 Aug 31;40(1):274. doi: 10.1186/s13046-021-02083-6.